Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Allergan Limited
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
An 8-Week, Multicenter, Masked, Randomized Trial (with an 18-Week Masked Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared with Sham DEX PS DDS Applicator System in the Treatment of Non Infectious Ocular Inflammation of the Posterior Segment in Patients with Intermediate or Posterior Uveitis
To evaluate the safety and efficacy of the 700 µg DEX PS DDS Applicator System (700 µg dexamethasone) and 350 µg DEX PS DDS Applicator System (350 µg dexamethasone) compared with Sham DEX PS DDS Appli...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
An Open Label (Stage 1) and Randomized (Stage 2), 24-Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
1. To evaluate the safety of an intracameral implant of Bimatoprost PF IC DDS in patients with open-angle glaucoma (OAG) and ocular hypertension (OHT) (OHT evaluated in Stage 2 patients only). 2. To...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A Double-Blind, Randomised, Parallel group, Safety and Efficacy Pilot Study Comparing Two Botulinum Toxin Type-A Products in the Treatment of Blepharospasm
To compare the efficacy of BOTOX® versus Xeomin® (≥25U/eye; ≥50U total dose) in the treatment of subjects with blepharospasm
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Allergan Limited
Update Il y a 4 ans
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
To explore the safety and efficacy profile of a range of doses of BOTOX for the treatment of premature ejaculation in male patients
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON Study)
The study objectives are to assess: (1) the safety of the treatment; (2) the effects of treatment on the mean change in atrophic lesion area quantified from fundus autofluorescence images; (3) the eff...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Explore the Dose Dependent Response to Three Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by an Open Label Extension Phase in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity
To explore the dose dependent response to 50 U, 100 U and 200 U BOTOX® when injected into the detrusor for the treatment of urinary incontinence caused by neurogenic detrusor overactivity in patients ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
Study of the efficacy and safety of BOTOX® in the treatment of facial wrinkles (crow's feet lines)
To evaluate the safety and efficacy of BOTOX compared to placebo in subjects with lateral canthal rhytides in the periorbital region (Crow's Feet Lines).
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A Six-Month, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Macular Oedema following Central Retinal Vein Occlusion or Branch Retinal Vein Occlusion
To evaluate the safety and efficacy of the 700 µg DEX PS DDS Applicator System (700 µg dexamethasone) and 350 µg DEX PS DDS Applicator System (350 µg dexamethasone) compared with a Sham DEX PS DDS App...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A study to evaluate the long-term safety and efficacy of BOTOX® for the treatment of urinary incontinence in patients 8 to 17 years of age
To evaluate the long-term safety and efficacy of BOTOX for the treatment of urinary incontinence due to Neurogenic Detrusor Overactivity (NDO) in patients 8 to 17 years of age who have not been adequa...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A study to compare a slow release formulation of bimatoprost with selective laser trabeculoplasty in patients with open-angle glaucoma or high pressure in the eye
To evaluate the intraocular pressure (IOP)-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty (SLT) in patients with open-angle glaucoma (OAG) or ocular hyperte...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3
4
Next